Search: onr:"swepub:oai:DiVA.org:uu-143627" >
Liver transplantati...
Liver transplantation for familial amyloidotic polyneuropathy (FAP) : a single-center experience over 16 years
-
- Yamamoto, Shinji (author)
- Karolinska Institutet,Uppsala universitet,Transplantationskirurgi
-
Wilczek, H E (author)
-
- Nowak, G (author)
- Karolinska Institutet
-
show more...
-
Larsson, M (author)
-
Oksanen, A (author)
-
Iwata, T (author)
-
- Gjertsen, H (author)
- Karolinska Institutet
-
Söderdahl, G (author)
-
Wikström, L (author)
-
Ando, Y (author)
-
- Suhr, Ole B (author)
- Umeå universitet,Medicin
-
- Ericzon, B-G (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- Elsevier BV, 2007
- 2007
- English.
-
In: American Journal of Transplantation. - : Elsevier BV. - 1600-6135 .- 1600-6143. ; 7:11, s. 2597-2604
- Related links:
-
https://onlinelibrar...
-
show more...
-
http://www.ncbi.nlm....
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- Orthotopic liver transplantation (LTx) is currently the only available treatment that has been proven to halt the progress of familial amyloidotic polyneuropathy (FAP). The aim of this study was to assess mortality and symptomatic response to LTx for FAP. All 86 FAP patients transplanted at our hospital between April 1990 and November 2005 were included in the study. Five patients underwent retransplantation. The 1-, 3- and 5-year patient survival rates in patients transplanted during 1996-2005 were 94.6%, 92.3% and 92.3%, respectively, a significant difference from the rates of 76.7%, 66.7% and 66.7%, respectively, during 1990-1995 (p = 0.0003). Multivariate analysis revealed that the age at the time of LTx (>or=40 years), duration of the disease (>or=7 years) and modified body mass index (mBMI) (<600) were independent prognostic factors for patient survival. A halt in the progress of symptoms was noted in most patients, but only a minority experienced an improvement after LTx. To optimize the posttransplant prognosis, LTx should be performed in the early stages of the disease, and close post-LTx monitoring of heart function by echocardiography and of heart arrhythmia by Holter ECG is mandatory.
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Yamamoto, Shinji
-
Wilczek, H E
-
Nowak, G
-
Larsson, M
-
Oksanen, A
-
Iwata, T
-
show more...
-
Gjertsen, H
-
Söderdahl, G
-
Wikström, L
-
Ando, Y
-
Suhr, Ole B
-
Ericzon, B-G
-
show less...
- Articles in the publication
-
American Journal ...
- By the university
-
Uppsala University
-
Umeå University
-
Karolinska Institutet